Related Experiment Video
Updated: May 2, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Synthetic approaches to the 2012 new drugs
Hong X Ding1, Carolyn A Leverett2, Robert E Kyne2
1PharmaPhase Co., Ltd, Beijing 100193, China.
Abstract:
New drugs introduced to the market every year represent a privileged structure for a particular biological target. These new chemical entities (NCEs) provide insights into molecular recognition and also serve as leads for designing future new drugs. This review covers the synthesis of twenty-six NCEs that were launched or approved worldwide in 2012 and two additional drugs which were launched at the end of 2011.
Related Concept Videos
Drug Discovery: Overview
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Drug Products: Biologics, Biosimilars and Interchangeables
Clinically Relevant Drug Product Specifications: Methods of Establishment
Pharmacogenomics: Identification of New Drug Targets

